Department of Microbiology
Nacho Aguilo has not added Biography.
If you are Nacho Aguilo and would like to personalize this page please email our Author Liaison for assistance.
Recent developments in tuberculosis vaccines.
Expert review of vaccines Dec, 2013 | Pubmed ID: 24195481
ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question.
Frontiers in cellular and infection microbiology , 2013 | Pubmed ID: 24364000
Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.
Clinical and vaccine immunology : CVI Apr, 2014 | Pubmed ID: 24501340
A human dendritic cell-based in vitro model to assess Mycobacterium tuberculosis SO2 vaccine immunogenicity.
ALTEX , 2014 | Pubmed ID: 24840067
A specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 component.
Infection and immunity Aug, 2014 | Pubmed ID: 24891105
Elucidating sources and roles of granzymes A and B during bacterial infection and sepsis.
Cell reports Jul, 2014 | Pubmed ID: 25017060
Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
Vaccine Sep, 2014 | Pubmed ID: 25066740
Mouse cytotoxic T cell-derived granzyme B activates the mitochondrial cell death pathway in a Bim-dependent fashion.
The Journal of biological chemistry Mar, 2015 | Pubmed ID: 25605735
Human NK cells activated by EBV(+) lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.
Oncoimmunology Mar, 2015 | Pubmed ID: 25949911
Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes.
Cellular microbiology Nov, 2015 | Pubmed ID: 26045209
Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent Mechanism.
The Journal of infectious diseases Mar, 2016 | Pubmed ID: 26494773
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
The Lancet. Respiratory medicine Dec, 2015 | Pubmed ID: 26598141
Evaluation of the immunogenicity and diagnostic interference caused by M. tuberculosis SO2 vaccination against tuberculosis in goats.
Research in veterinary science Dec, 2015 | Pubmed ID: 26679799
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.
Tuberculosis (Edinburgh, Scotland) Jan, 2016 | Pubmed ID: 26786657
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo.
PloS one , 2016 | Pubmed ID: 27055232
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。